See more : Italy Innovazioni S.p.A. (MLITN.PA) Income Statement Analysis – Financial Results
Complete financial analysis of Magellan Health, Inc. (MGLN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Magellan Health, Inc., a leading company in the Medical – Healthcare Plans industry within the Healthcare sector.
- American Equity Investment Life Holding Company (AEL-PA) Income Statement Analysis – Financial Results
- Scandinavian Tobacco Group A/S (SNDVF) Income Statement Analysis – Financial Results
- Whitehorse Gold Corp. (WHGDF) Income Statement Analysis – Financial Results
- C2E Energy, Inc. (OOGI) Income Statement Analysis – Financial Results
- PT TIMAH Tbk (TINS.JK) Income Statement Analysis – Financial Results
Magellan Health, Inc. (MGLN)
About Magellan Health, Inc.
Magellan Health, Inc., together with its subsidiaries, provides healthcare management services in the United States. The company operates in Healthcare and Pharmacy Management segments. The Healthcare segment offers carve-out management services for behavioral health; employee assistance plans; and other areas of specialty healthcare, including diagnostic imaging, musculoskeletal management, cardiac, and physical medicine. It also contracts with state Medicaid agencies, and the centers for Medicare and Medicaid services to manage care for beneficiaries under Medicaid and Medicare programs, such as healthcare and long-term support services through its network of medical and behavioral health professionals, clinics, hospitals, nursing facilities, home care agencies, and ancillary service providers. The Pharmacy Management segment comprises products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Further, it offers pharmacy benefit management services, such as pharmaceutical dispensing services; pharmacy benefit administration for state Medicaid and other government sponsored programs; clinical and formulary management programs; medical pharmacy management programs; and programs for the integrated management of specialty drugs that treat complex conditions. In addition, the company provides services to health plans and managed care organizations, employers, labor unions, third party administrators, state governments, military and governmental agencies, exchanges, brokers, and consultants. Magellan Health, Inc. was incorporated in 1969 and is headquartered in Phoenix, Arizona. As of January 4, 2022, Magellan Health, Inc. operates as a subsidiary of Centene Corporation.
| Metric | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.58B | 7.16B | 7.31B | 5.84B | 4.84B | 4.60B | 3.76B | 3.55B | 3.21B | 2.80B | 2.97B | 2.64B | 2.63B | 2.16B | 1.69B | 1.81B | 1.80B | 1.51B | 445.89M | 1.76B | 1.87B | 1.87B | 1.51B | 1.21B | 1.35B | 1.15B | 904.65M |
| Cost of Revenue | 4.46B | 6.93B | 7.12B | 5.57B | 4.58B | 4.42B | 3.55B | 3.31B | 2.96B | 2.02B | 2.13B | 2.43B | 2.44B | 1.96B | 1.51B | 1.57B | 0.00 | 1.32B | 0.00 | 1.56B | 1.65B | 1.66B | 1.29B | 978.51M | 0.00 | 0.00 | 0.00 |
| Gross Profit | 118.79M | 229.29M | 197.18M | 271.02M | 258.94M | 178.38M | 215.08M | 238.19M | 249.58M | 782.64M | 842.63M | 207.46M | 186.87M | 193.26M | 181.90M | 241.62M | 1.80B | 185.86M | 445.89M | 198.47M | 220.97M | 208.01M | 217.97M | 232.18M | 1.35B | 1.15B | 904.65M |
| Gross Profit Ratio | 2.60% | 3.20% | 2.70% | 4.64% | 5.35% | 3.88% | 5.72% | 6.72% | 7.78% | 27.96% | 28.38% | 7.85% | 7.12% | 8.96% | 10.76% | 13.36% | 100.00% | 12.30% | 100.00% | 11.31% | 11.79% | 11.11% | 14.41% | 19.18% | 100.00% | 100.00% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.59B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 0.00 | 0.00 | 0.00 | 0.00 | 876.61M | 822.39M | 723.50M | 619.55M | 557.51M | 529.63M | 566.58M | 0.00 | 0.00 | 0.00 | 0.00 | 15.81M | 1.59B | 0.00 | 391.43M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 98.39M | 131.51M | 132.66M | 115.71M | -770.57M | -719.55M | -632.43M | -547.55M | -497.02M | 58.62M | 54.68M | 47.27M | 60.81M | 57.52M | 48.86M | 49.09M | 42.49M | 358.06M | 14.38M | 35.07M | 91.02M | 63.79M | 103.54M | 163.71M | 1.23B | 1.15B | 922.79M |
| Operating Expenses | 98.39M | 131.51M | 132.66M | 115.71M | 106.05M | 102.84M | 91.07M | 71.99M | 60.49M | 588.26M | 621.26M | 47.27M | 60.81M | 57.52M | 48.86M | 64.90M | 1.63B | 358.06M | 405.81M | 35.07M | 91.02M | 63.79M | 103.54M | 163.71M | 1.23B | 1.15B | 922.79M |
| Cost & Expenses | 4.56B | 7.06B | 7.25B | 5.68B | 4.68B | 4.52B | 3.64B | 3.38B | 3.02B | 2.61B | 2.75B | 2.48B | 2.50B | 2.02B | 1.56B | 1.63B | 1.63B | 1.68B | 405.81M | 1.59B | 1.74B | 1.73B | 1.40B | 1.14B | 1.23B | 1.15B | 922.79M |
| Interest Income | 4.05M | 19.19M | 14.07M | 5.89M | 2.82M | 2.17M | 1.30M | 1.99M | 2.02M | 2.78M | 3.28M | 6.25M | 17.03M | 23.84M | 17.63M | 17.46M | 6.13M | 2.87M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 30.87M | 36.15M | 35.40M | 25.98M | 10.19M | 6.58M | 7.39M | 3.00M | 2.25M | 2.50M | 2.23M | 2.42M | 2.85M | 6.39M | 7.29M | 44.01M | 37.12M | 61.02M | 873.00K | -8.80M | -83.00M | -18.41M | -38.31M | -14.36M | -6.16M | 0.00 | -12.62M |
| Depreciation & Amortization | 118.75M | 131.51M | 132.66M | 115.71M | 106.05M | 102.84M | 91.07M | 71.99M | 60.49M | 58.62M | 54.68M | 47.27M | 60.81M | 57.52M | 48.86M | 49.09M | 42.49M | 48.05M | 14.38M | 70.28M | 79.24M | 73.53M | 54.89M | 44.86M | 48.92M | 64.09M | 59.55M |
| EBITDA | 487.41M | 248.48M | 211.25M | 276.97M | 263.85M | 183.25M | 221.55M | 240.18M | 251.60M | 255.79M | 279.32M | 213.70M | 203.90M | 216.74M | 205.11M | 306.09M | 214.57M | 594.65M | 29.24M | 131.22M | 28.91M | 105.60M | 55.64M | 53.60M | 107.00M | 9.82M | -10.60M |
| EBITDA Ratio | 10.65% | 3.47% | 2.89% | 4.74% | 5.45% | 3.99% | 5.89% | 6.77% | 7.84% | 9.14% | 9.41% | 8.09% | 7.77% | 10.05% | 12.13% | 16.93% | 11.95% | 39.36% | 6.56% | 7.47% | 1.54% | 5.64% | 3.68% | 4.43% | 7.95% | 0.85% | -1.17% |
| Operating Income | 368.67M | 116.97M | 78.59M | 161.27M | 157.80M | 80.40M | 130.48M | 168.19M | 191.11M | 197.16M | 224.64M | 166.43M | 143.09M | 159.21M | 156.25M | 257.00M | 172.08M | 546.60M | 14.86M | 60.94M | -50.33M | 32.06M | 750.00K | 8.74M | 58.08M | -54.27M | -70.16M |
| Operating Income Ratio | 8.05% | 1.63% | 1.07% | 2.76% | 3.26% | 1.75% | 3.47% | 4.74% | 5.96% | 7.04% | 7.57% | 6.30% | 5.45% | 7.38% | 9.24% | 14.21% | 9.58% | 36.18% | 3.33% | 3.47% | -2.69% | 1.71% | 0.05% | 0.72% | 4.32% | -4.71% | -7.75% |
| Total Other Income/Expenses | -409.15M | -36.15M | -35.40M | -26.04M | -12.28M | -9.29M | -12.56M | -3.00M | -2.25M | -2.50M | -2.23M | -2.42M | -2.85M | -6.03M | -7.33M | -45.54M | -40.54M | -60.82M | -873.00K | 8.80M | 83.00M | 18.41M | 38.31M | 14.36M | 6.16M | 0.00 | 12.62M |
| Income Before Tax | -40.49M | 80.82M | 43.19M | 135.22M | 145.52M | 71.12M | 117.92M | 165.19M | 188.87M | 194.66M | 222.40M | 164.01M | 140.24M | 153.19M | 148.92M | 211.46M | 131.54M | 485.78M | 13.99M | 69.74M | 32.67M | 50.47M | 39.06M | 23.10M | 64.24M | -54.27M | -57.54M |
| Income Before Tax Ratio | -0.88% | 1.13% | 0.59% | 2.32% | 3.01% | 1.55% | 3.14% | 4.66% | 5.89% | 6.95% | 7.49% | 6.21% | 5.34% | 7.11% | 8.81% | 11.70% | 7.33% | 32.16% | 3.14% | 3.97% | 1.74% | 2.70% | 2.58% | 1.91% | 4.78% | -4.71% | -6.36% |
| Income Tax Expense | -44.53M | 24.92M | 19.01M | 25.08M | 69.73M | 42.41M | 43.69M | 39.92M | 37.84M | 65.04M | 83.74M | 57.34M | 54.04M | 58.67M | 62.70M | 82.41M | 46.58M | 33.81M | 3.13M | 36.39M | 15.48M | 27.38M | 20.03M | 9.24M | 25.70M | -11.31M | -10.54M |
| Net Income | 4.05M | 55.90M | 24.18M | 110.14M | 75.79M | 28.71M | 74.23M | 125.26M | 151.03M | 129.62M | 138.66M | 106.67M | 86.21M | 94.52M | 86.22M | 129.05M | 84.95M | 451.97M | 10.86M | 33.35M | 17.19M | 23.10M | 19.03M | 13.86M | 38.54M | -42.96M | -47.00M |
| Net Income Ratio | 0.09% | 0.78% | 0.33% | 1.89% | 1.57% | 0.62% | 1.97% | 3.53% | 4.71% | 4.63% | 4.67% | 4.04% | 3.28% | 4.38% | 5.10% | 7.14% | 4.73% | 29.92% | 2.43% | 1.90% | 0.92% | 1.23% | 1.26% | 1.14% | 2.87% | -3.73% | -5.20% |
| EPS | 0.16 | 2.28 | 0.97 | 4.72 | 3.27 | 1.15 | 2.78 | 4.63 | 5.51 | 4.25 | 4.10 | 3.03 | 2.18 | 2.43 | 2.33 | 3.59 | 2.40 | 12.80 | 0.31 | 1.00 | 0.53 | 0.73 | 0.62 | 0.47 | 1.24 | -1.54 | -1.78 |
| EPS Diluted | 0.16 | 2.28 | 0.97 | 4.51 | 3.14 | 1.11 | 2.71 | 4.53 | 5.42 | 4.17 | 4.03 | 3.01 | 2.16 | 2.37 | 2.23 | 3.42 | 2.34 | 10.86 | 0.26 | 0.81 | 0.53 | 0.72 | 0.61 | 0.46 | 1.24 | -1.54 | -1.78 |
| Weighted Avg Shares Out | 25.78M | 24.56M | 25.04M | 23.33M | 23.18M | 24.87M | 26.69M | 27.05M | 27.39M | 30.48M | 33.78M | 35.25M | 39.61M | 38.94M | 36.99M | 35.97M | 35.37M | 35.31M | 35.14M | 33.45M | 32.14M | 31.76M | 30.78M | 29.47M | 31.01M | 27.87M | 26.39M |
| Weighted Avg Shares Out (Dil) | 25.78M | 24.56M | 25.04M | 24.44M | 24.16M | 25.88M | 27.36M | 27.68M | 27.88M | 31.06M | 34.44M | 35.42M | 40.00M | 39.84M | 38.62M | 37.69M | 36.36M | 41.61M | 41.44M | 41.24M | 32.39M | 31.92M | 31.20M | 30.17M | 31.01M | 27.87M | 26.39M |
Magellan (MGLN) Q2 Earnings Decline Y/Y on High Expenses
Magellan Health Reports Second Quarter 2021 Financial Results
Magellan Rx Management and Heuro Health Collaborate to Offer Live Behavioral Health Support and Wellness Coaching
Fast-paced Momentum Stock Magellan Health (MGLN) Is Still Trading at a Bargain
Magellan's (MGLN) Unit Ties Up to Boost ASD Patient Outcomes
Magellan Healthcare and Invo Healthcare Announce Value-Based Care Collaboration Focused on Improved Autism Outcomes
Magellan Healthcare Hosts Webinars in Support of BIPOC Mental Health Awareness Month in July
Magellan (MGLN) Unit Generates Cost Savings With Biosimilars
Magellan Rx Management Oncology Biosimilar Solution Delivers $40M+ in Annualized Savings for Early Adopter Health Plans
Magellan Rx Management's Medical Pharmacy Trend Report Unlocks the Latest Trends and Emerging Strategies to Manage Rising Medical Benefit Specialty Drug Spend
Source: https://incomestatements.info
Category: Stock Reports